SureTrader
Home > Boards > US Listed > Biotechs >

Incyte Corporation (INCY)

INCY RSS Feed 		Add INCY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/6/2018 9:29:10 AM - Followers: 25 - Board type: Free - Posts Today: 0

http://www.incyte.com/

http://finance.yahoo.com/q/ks?s=INCY

http://www.form4oracle.com/company?cik=0000879169&ticker=incy

Incyte Corporation is a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases. The company's CCR2 program is being developed under collaboration with Pfizer, Inc. for inflammatory diseases. Its pipeline also includes sheddase inhibitor (INCB7839), which is in phase IIa clinical trials for solid tumors; CCR5 antagonists for HIV, including INCB9471 in phase IIa and INCB15050 in phase I clinical trials; and 11�HSD1 inhibitor (INCB13739), which is in phase IIa clinical trial for type 2 diabetes. The company also has preclinical programs under development, such as JAK 2 Program for inflammatory diseases, myeloproliferative disorders, and cancer. Incyte offers its products in the United States, Canada, Germany, Sweden, and the United Kingdom. The company was founded in 1991 and is headquartered in Wilmington, Delaware.



SureTrader
INCY
Current Price
Volume:
Bid Ask Day's Range
INCY Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
INCY News: Incyte to Report First Quarter Financial Results 04/13/2018 08:00:00 AM
INCY News: Statement of Changes in Beneficial Ownership (4) 04/11/2018 04:56:15 PM
INCY News: Initial Statement of Beneficial Ownership (3) 04/11/2018 04:44:33 PM
INCY News: Statement of Changes in Beneficial Ownership (4) 04/09/2018 05:02:52 PM
INCY News: Incyte und MSD melden Aktualisierung der Phase-III-Studie zur Wirksamkeit von Epacadostat in Kombination mit KEYTRUDA® (Pemb... 04/07/2018 02:45:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#202   Got lucky. Have been eyeing it more closely chmcnfunds 04/06/18 09:29:10 AM
#201   Fantastic great sale, Kyle Dennis and Country Squire 04/06/18 09:09:45 AM
#200   Sold @ $90.50 to take profits. Has moved chmcnfunds 03/05/18 02:47:53 PM
#199   Back in INCY @ $81.85. 52 week low. chmcnfunds 03/01/18 10:13:30 AM
#198   So glad sold @ $89.10 yesterday toward the chmcnfunds 02/15/18 09:38:12 AM
#197   How Incyte’s Jakafi Performed in 3Q17 chmcnfunds 01/10/18 08:43:12 AM
#196   Was thinking the same. Hope this will pass chmcnfunds 01/09/18 01:59:26 PM
#195   Herve made it clear that being taken over hogar 01/09/18 01:04:51 PM
#194   CEO interview: chmcnfunds 01/09/18 08:24:36 AM
#193   FWIW: Jim Cramer Advises His Viewers On Incyte And chmcnfunds 01/08/18 08:40:35 AM
#192   Incyte and Syros Announce Global Target Discovery and chmcnfunds 01/08/18 08:30:23 AM
#191   As long as they don't turn out like KATX. Spudskie 12/22/17 04:53:22 PM
#190   3 Promising Cancer Immunotherapies to Watch in 2018 chmcnfunds 12/22/17 10:32:38 AM
#189   Biotech Pullback Makes Bargains Out Of Alexion, Flexion, chmcnfunds 11/29/17 12:09:11 PM
#188   In Incyte for the 1st time @ $99.25. chmcnfunds 11/21/17 10:04:23 AM
#187   https://seekingalpha.com/article/4124190-bristol-myers-squibb-brings-ace-card-mi Inoviorulez 11/13/17 09:21:18 AM
#186   I have seen no evidence to support that north40000 10/25/17 03:04:08 PM
#185   INCY’s own PD-1 candidate (#msg-116696022) is apparently dead. DewDiligence 10/25/17 12:02:32 PM
#184   MGNX/INCY deal is + for both, so far today. north40000 10/25/17 11:05:20 AM
#183   Not so surprising....One expects a fairly high failure shub 08/01/17 02:58:24 PM
#182   They stopped some trials: DewDiligence 08/01/17 02:53:00 PM
#181   Let's see here; We've got a pipeline full shub 08/01/17 02:34:39 PM
#180   http://www.mdedge.com/rheumatologynews/article/104503/rheumatoid-arthritis/baric koman 04/17/17 10:16:39 AM
#179   FDA CRL on INCY/LLY data re med for north40000 04/17/17 08:01:49 AM
#178   Baker Brothers selling all or a big chunk FreeNorth 03/10/17 06:42:10 PM
#177   We join the S&P 500, which means index shub 02/24/17 02:36:19 PM
#176   they will partner w/ ? Fibanotch 02/15/17 10:08:40 AM
#175   This 10yr DCF valuation analyses implies Incyte $INCY ValueInvestor15 02/13/17 09:39:53 AM
#174   (Good news for INCY)—GILD’s Momelotinib goes 1-for-2 in DewDiligence 11/16/16 05:26:48 PM
#173   What's going on today?? new investments 11/09/16 09:56:23 AM
#172   Incyte Corp fundamental analysis highlights shares are ~15% ValueInvestor15 10/31/16 02:32:03 PM
#171   Hello!? Hello?! Invest83838 08/23/16 05:39:47 PM
#170   Watching this closely now. inversor86 01/29/16 02:44:20 AM
#169   INCY 10 MINUTES TREND1 11/21/15 06:18:37 PM
#168   Cowen and Jefferis are out with reports defending magness 11/06/15 02:35:11 PM
#167   44% swing in one week. Crazy! 4starman 10/02/15 04:14:03 PM
#166   $INCY recent news/filings stocktrademan 08/30/15 09:56:08 AM
#165   FLOAT = 137M TREND1 07/31/15 01:45:49 PM
#164   INCY W TREND1 07/22/15 03:51:22 PM
#163   INCY 30 MINUTES TREND1 07/17/15 01:21:59 PM
#162   THE CHARTIST follows this stock. TREND1 07/17/15 01:18:25 PM
#161   Inst % Owned = 95% TREND1 07/17/15 01:17:02 PM
#160   INCY W TREND1 07/16/15 11:09:34 PM
#159   $INCY DD Notes ~ http://www.ddnotesmaker.com/INCY stocktrademan 12/12/14 12:27:11 PM
#158   $INCY DD Notes ~ http://www.ddnotesmaker.com/INCY stocktrademan 10/29/14 09:28:11 AM
#157   INCY LABEL EXPANSION NEWS [SMART MONEY] 07/28/14 08:35:53 AM
#156   12:45PM Incyte: Jakafi (ruxolitinib) continues to show improved surf1944 12/09/13 02:13:54 PM
#155   2:13AM Incyte presents positive results from proof-of-concept Phase surf1944 10/29/13 09:44:13 AM
#154   investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=1850254&hig FreeNorth 09/02/13 01:27:06 AM
#153   Mid-stage trial promising: Up almost $9 http://www.reuters.com/article/2013/08/2 mlkrborn 08/21/13 01:51:37 PM
PostSubject
© 2018 InvestorsHub.com, Inc.